Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
BlackRock, Inc. reported a 7.80% stake in Agios Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 7.80% stake in Agios Pharmaceuticals, Inc., 4,513,170 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 4,513,170
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.80% | 4,513,170 |
Source
Related
- Agios Pharmaceuticals, Inc.
- BlackRock, Inc.
- Agios Pharmaceuticals, Inc. shareholders
- Form 4 · Gheuens Sarah · Aug 6, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 3, 2026
- Form 4 · Backstrom Jay T. · Jul 10, 2026
- Form 4 · Gheuens Sarah · Jul 2, 2026
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026